Director at Core Scientific (NASDAQ: CORZ) receives 18,961-share RSU equity grant

Rhea-AI Filing Summary

Smith Stephen M reported acquisition or exercise transactions in this Form 4 filing.

Core Scientific director Stephen M. Smith received a grant of 18,961 shares of Common Stock in the form of restricted stock units. The RSUs were granted at no cash cost and will vest in two substantially equal installments on May 26, 2027 and May 26, 2028, contingent on his continued service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Smith Stephen M

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18,961	$0.00	--

Holdings After Transaction: Common Stock — 18,961 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 18,961 shares Transaction price: $0.0000 per share Holdings after grant: 18,961 shares +2 more

5 metrics

RSU grant size 18,961 shares Restricted stock unit grant of Common Stock

Transaction price $0.0000 per share RSU grant issued at no cash cost

Holdings after grant 18,961 shares Total Common Stock reported following transaction

First vesting date May 26, 2027 First substantially equal RSU installment vests

Second vesting date May 26, 2028 Second substantially equal RSU installment vests

Key Terms

restricted stock unit ("RSU"), vest, grant, award, or other acquisition

3 terms

restricted stock unit ("RSU") financial

"Represents a restricted stock unit ("RSU") grant."

vest financial

"The RSUs will vest in two substantially equal installments on May 26, 2027 and May 26, 2028"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Stephen M

(Last) (First) (Middle)

C/O CORE SCIENTIFIC, INC.

838 WALKER ROAD, SUITE 21-2105

(Street)

DOVER DELAWARE 19904

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/26/2026		A		18,961(1)	A	$0	18,961	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") grant. The RSUs will vest in two substantially equal installments on May 26, 2027 and May 26, 2028, provided that the Reporting Person continues to provide service to the Issuer on each vesting date.

	/s/ Todd DuChene, as Attorney-in-Fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Core Scientific (CORZ) report for Stephen M. Smith?

Core Scientific reported that director Stephen M. Smith received 18,961 restricted stock units of Common Stock as a grant. The award carries no cash exercise price and represents equity-based compensation linked to his continued service with the company.

How many Core Scientific (CORZ) shares did Stephen M. Smith acquire in this Form 4?

Stephen M. Smith acquired 18,961 shares of Core Scientific Common Stock in the form of restricted stock units. Following this grant, his reported direct holdings total 18,961 shares, all tied to the vesting conditions described in the award.

What are the vesting terms of Stephen M. Smith’s Core Scientific (CORZ) RSU grant?

The RSU grant to Stephen M. Smith will vest in two substantially equal installments on May 26, 2027 and May 26, 2028. Vesting is conditioned on his continued service to Core Scientific on each respective vesting date.

Did Stephen M. Smith pay a price per share for the Core Scientific (CORZ) RSU grant?

No, the RSU grant to Stephen M. Smith shows a transaction price per share of $0.0000. This indicates it is a compensation-related equity award rather than an open-market purchase requiring cash payment for the shares.

Is the Core Scientific (CORZ) Form 4 transaction a market buy or sell by Stephen M. Smith?

The Form 4 reflects an acquisition through a grant of restricted stock units, not a market buy or sell. It is coded as a grant, award, or other acquisition and represents stock-based compensation instead of an open-market transaction.